HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Animal models of multiple system atrophy.

Abstract
Multiple system atrophy (MSA) is a sporadic adult-onset neurodegenerative disorder clinically characterized by a variable combination of dysautonomia, levodopa-unresponsive parkinsonian and cerebellar symptoms. Neurodegeneration in MSA occurs in the substantia nigra, putamen, inferior olive, pontine and brainstem nuclei, as well as intermediolateral cell column of the spinal cord. MSA is recognized as a synucleinopathy due to the accumulation of insoluble alpha-synuclein in oligodendroglial cytoplasmic inclusions. Several animal models have been developed in order to reproduce various clinical and pathological features of MSA. Using "double toxin-double lesion" or "single toxin-double lesion", neurotoxin-based models were designed in rats, mice and non-human primates to reproduce the neuropathology of MSA in the nigrostriatal system while gene-based models were developed in mice to reproduce the accumulation of insoluble alpha-synuclein in oligodendrocytes. Both approaches have then been merged to create optimized, dual-hit models. This review describes the different animal models of MSA, their respective advantages and limitations and their usefulness to decipher the pathophysiology of MSA then to define efficient symptomatic and disease-modifying therapies. This article is part of a Special Issue entitled: Neuroscience Disease Models.
AuthorsP-O Fernagut, F Tison
JournalNeuroscience (Neuroscience) Vol. 211 Pg. 77-82 (Jun 01 2012) ISSN: 1873-7544 [Electronic] United States
PMID21963351 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Neurotoxins
  • alpha-Synuclein
Topics
  • Animals
  • Corpus Striatum (pathology)
  • Disease Models, Animal
  • Multiple System Atrophy (chemically induced, genetics, pathology)
  • Nerve Degeneration (chemically induced, pathology)
  • Neurotoxins (toxicity)
  • Substantia Nigra (pathology)
  • alpha-Synuclein (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: